December 17, 2024 Maria Dranishnikova MAIA soars after its cancer drug receives FDA ‘rare pediatric disease’ designation
November 18, 2024 Maria Dranishnikova Citius Pharmaceuticals plunges to all-time low after direct offering announced
October 25, 2024 Viktoriya Sirota Potential Eli Lilly and Novo Nordisk competitor surges 21% on third-quarter financials
October 8, 2024 Maria Dranishnikova Scholar Rock stock skyrockets on positive trial data for its SMA drug
October 7, 2024 Maria Dranishnikova Zacks SCR sees massive upside in vaccine maker Soligenix amid Marburg virus outbreak
August 20, 2024 Yevgeniya Vatamaniuk Shares of monkeypox treatment maker GeoVax surge 50% amid news flow
August 14, 2024 Maria Dranishnikova Zacks spotlights stock of perinatal-tissue therapy developer as undervalued
July 29, 2024 Maria Dranishnikova Alzheimer’s drug developer ProMIS loses over 20% of market capitalization in a day